Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
VEGF therapy for the kidney: emerging strategies
Erika Guise1, Alejandro R Chade1,2,3
1Department of Physiology and Biophysics, University of Mississippi Medical Center , Jackson, Mississippi.
Vascular endothelial growth factor (VEGF) therapy shows promise for protecting the kidney in renovascular disease (RVD). This approach aims to prevent further kidney damage by improving renal microvessel function and repair.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Vascular Biology
Background:
- Renovascular disease (RVD) is common in older adults, increasing cardiovascular risk and leading to kidney function decline.
- RVD causes damage to renal microvessels, impaired vascular repair, and reduced vascular endothelial growth factor (VEGF) bioavailability.
- Protecting renal microvasculature is a key strategy to halt progressive renal injury in RVD.
Purpose of the Study:
- To review recent research on the potential of VEGF therapy for kidney protection.
- To explore the mechanisms by which VEGF may offer renoprotection in the context of RVD.
Main Methods:
- Literature review of recent studies on VEGF therapy and kidney protection.
- Analysis of mechanisms underlying VEGF's role in renal microvascular health and repair.
Main Results:
- Recent studies suggest VEGF therapy has potential applications for renoprotection.
- VEGF may counteract RVD-induced renal microvascular dysfunction and promote repair.
Conclusions:
- VEGF therapy represents a promising avenue for treating kidney damage associated with renovascular disease.
- Targeting VEGF could be a strategy to preserve renal function in patients with RVD.
Related Concept Videos
Emerging Adulthood
Kidney Structure
Introduction Cardiac Emergencies
Gene Therapy
Applications of GIS: Disaster Management and Emergency Response
Group Therapy

